Pahal G, Jauniaux E, Kinnon C, Thrasher AJ and Rodeck CH (2000) Normal development of human fetal hematopoiesis between eight and seventeen weeks’ gestation. Am J Obstet Gynecol, 183, 1029–1034.119 119 Kumar BV, Connors T and Farber DL (2018) Human T cell development, localization, and function throughout life. Immunity, 48, 202–213.
120 120 Krause PJ, Herson VC, Boutin‐Lebowitz J, Eisenfeld L, Block C, LoBello T et al. (1986) Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res, 20, 296–300.
121 121 Anderson DC, Rothlein R, Marlin SD, Krater SS AND Smith CW (1990) Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac‐1 (CD11b/CD18)‐dependent adherence reactions. Blood, 76, 2613–2621.
122 122 Nussbaum C, Gloning A, Pruenster M, Frommhold D, Bierschenk S, Genzel‐Boroviczény O et al. (2013) Neutrophil and endothelial adhesive function during human fetal ontogeny. J Leukoc Biol, 93, 175–184.
123 123 Yost CC, Cody MJ, Harris ES, Thornton NL, McInturff AM, Martinez ML et al. (2009) Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood, 113, 6419–6427.
124 124 Lipp P, Ruhnau J, Lange A, Vogelgesang A, Dressel A and Heckmann M (2016) Less neutrophil extracellular trap formation in term newborns than in adults. Neonatology, 111, 182–188.
125 125 Yost CC, Schwertz H, Cody MJ, Wallace JA, Campbell RA, Vieira‐de‐Abreu A et al. (2016) Neonatal NET‐inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J Clin Invest, 126, 3783–3798.
126 126 Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol, 18, 134–147.
127 127 He Y‐M, Li X, Perego M, Nefedova Y, Kossenov AV, Jensen EA et al. (2018) Transitory presence of myeloid‐derived suppressor cells in neonates is critical for control of inflammation. Nat Med, 24, 224–231.
128 128 Weber R and Umansky V (2019) Fighting infant infections with myeloid‐derived suppressor cells. J Clin Invest, 129, 4080–4082.
129 129 Källman J, Schollin J, Schalèn C, Erlandsson A and Kihlström E (1998) Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed, 78, F46–F50.
130 130 Forestier F, Daffos F, Catherine N, Renard M and Andreux JP (1991) Developmental hematopoiesis in normal human fetal blood. Blood, 77, 2360–2363.
131 131 Hohlfeld P, Forestier F, Kaplan C, Tissot JD and Daffos F (1994) Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood, 84, 1851–1856.
132 132 Ferrer‐Marin F, Liu ZJ, Gutti R and Sola‐Visner M (2010) Neonatal thrombocytopenia and megakaryocytopoiesis. Semin Hematol, 47, 281–288.
133 133 Liu ZJ, Italiano J, Ferrer‐Marin F, Gutti R, Bailey M, Poterjoy B et al. (2011) Developmental differences in megakaryocytopoiesis are associated with up‐regulated TPO signalling through mTOR and elevated GATA‐1 levels in neonatal megakaryocytes. Blood, 117, 4106–4117.
134 134 Wolber E‐M, Bame C, Fahnenstich H, Hofmann D, Bartmann P, Jelkmann W and Fandrey J (1999) Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood, 94, 97–105.
135 135 Walka MM, Sonntag J, Dudenhausen JW and Obladen M (1999) Thrombopoietin concentration in umbilical cord blood of healthy term newborns is higher than in adult controls. Biol Neonate, 75, 54–58.
136 136 Murray NA, Watts TL, and Roberts IAG (1998) Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res, 43, 148–151.
137 137 Sola MC, Calhoun DA, Hutson AD and Christensen RD (1999) Plasma thrombopoietin concentrations in thrombocytopenic and non‐thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol, 104, 90–92.
138 138 Hegyi E, Nakazawa M, Debili N, Navarro S, Katz A, Breton‐Gorius J and Vainchenker W (1991) Developmental changes in human megakaryocyte ploidy. Exp Hematol, 19, 87–94.
139 139 Sola‐Visner M (2012) Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impacts on therapies. Hematology Am Soc Hematol Educ Program, 2012, 506–511.
140 140 Roberts IAG and Chakravorty S (2019) Thrombocytopenia in the newborn. In: Michelson A, Cataneo M, Frelinger A and Newman P (eds), Platelets, 4th edn. Academic Press, New York, pp. 813–831.
141 141 Sola‐Visner MC, Christensen RD, Hutson AD and Rimsza LM (2007) Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and non‐thrombocytopenic neonates. Pediatr Res, 61, 479–484.
142 142 Davenport P, Liu ZJ and Sola‐Visner M (2020) Changes in megakaryopoiesis over ontogeny and their implications in health and disease. Platelets, 31, 692–699.
143 143 Murray NA and Roberts IAG (1995) Circulating megakaryocytes and their progenitors (BFU‐MK and CFU‐MK) in term and pre‐term neonates. Br J Haematol, 89, 41–46.
144 144 Saxonhouse MA, Christensen RD, Walker DM, Hutson AD and Sola MC (2004) The concentration of circulating megakaryocyte progenitors in preterm neonates is a function of post‐conceptional age. Early Hum Dev, 78, 119–124.
145 145 Saxonhouse MA, Sola MC, Pastos KM, Ignatz ME, Hutson AD, Christensen RD and Rimsza LM (2004) Reticulated platelet percentages in term and preterm neonates. J Pediatr Hematol Oncol, 26, 797–802.
146 146 Wiedmeier SE, Henry E, Sola‐Visner MC and Christensen RD (2009) Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multi hospital healthcare system. J Perinatol, 29, 130–136.
147 147 Cremer M, Sallmon H, Kling PJ, Buhrer C and Dame C (2016) Thrombocytopenia and platelet transfusion in the neonate. Semin Fetal Neonatal Med, 21, 10–18.
148 148 MacQueen BC, Christensen RD, Henry E, Romrell AM, Pysher TJ, Bennett ST and Sola‐Visner MC (2017) The immature platelet fraction: creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias. J Perinatol, 37, 834–838.
149 149 Lorenz V, Ferrer‐Marin, Israels SJ and Sola‐Visner M (2019) Platelet function in the newborn. In: Michelson A, Cataneo M, Frelinger A and Newman P (eds), Platelets, 4th edn. Academic Press, New York, pp. 443–457.
150 150 Corby DG and O’Barr TP (1981) Decreased alpha‐adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther, 2, 215–225.
151 151 Caparros‐Perez E, Teruel‐Montoya R, Lopez‐Andreo MJ, Llanos MC, Rivera J, Palma‐Barqueros V et al. (2017) Comprehensive comparison of neonate and adult human platelet transcriptomes. PLoS One, 12, e0183042.
152 152 Sitaru AG, Holzhauer S, Speer CP, Singer D, Obergfell A, Walter U, Grossmann R et al. (2005) Neonatal platelets from cord blood and peripheral blood. Platelets, 16, 203–210.
153 153 Bednarek FJ, Bean S, Barnard MR, Frelinger AL and Michelson AD (2009) The platelet hyporeactivity of extremely low birth weight neonates is age‐dependent. Thromb Res, 124, 42–45.
154 154 Grevsen AK, Hviid CVB, Haansen AK and Hvas A‐M (2021) Platelet count and function in umbilical cord blood versus peripheral
